Increased plasma AACT level as an indicator of poor prognosis in patients hospitalised with community-acquired pneumonia: a multicentre prospective cohort study-Reference-Cited by-同舟云学术

Increased plasma AACT level as an indicator of poor prognosis in patients hospitalised with community-acquired pneumonia: a multicentre prospective cohort study

Published:2024-09-09 Issue:1 Volume:24 Page:
ISSN:1471-2334
Container-title:BMC Infectious Diseases
language:en
Short-container-title:BMC Infect Dis

Author:

Zhao Lili,Xi Wen,Shang Ying,Gao Wenjun,Bian Wenjie,Chen Xi,Xue Jianbo,Xu Yu,Gong Pihua,Guo Shuming,Gao Zhancheng

Funder

Chinese Science and Technology Key Project

National and Provincial Key Clinical Specialty Capacity Building Project 2020

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s12879-024-09742-x.pdf

Reference38 articles.

1. Aliberti S, Dela Cruz CS, Amati F, Sotgiu G, Restrepo MI. Community-acquired pneumonia. Lancet (London England). 2021;398(10303):906–19. https://doi.org/10.1016/s0140-6736(21)00630-9.

2. Prina E, Ranzani OT, Torres A. Community-acquired pneumonia. Lancet (London England). 2015;386(9998):1097–108. https://doi.org/10.1016/s0140-6736(15)60733-4.

3. Song JH, Oh WS, Kang CI, Chung DR, Peck KR, Ko KS, et al. Epidemiology and clinical outcomes of community-acquired pneumonia in adult patients in Asian countries: a prospective study by the Asian network for surveillance of resistant pathogens. Int J Antimicrob Agents. 2008;31(2):107–14. https://doi.org/10.1016/j.ijantimicag.2007.09.014.

4. Nair GB, Niederman MS. Updates on community acquired pneumonia management in the ICU. Pharmacol Ther. 2021;217:107663. https://doi.org/10.1016/j.pharmthera.2020.107663.

5. Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax. 2012;67(1):71–9. https://doi.org/10.1136/thx.2009.129502.